Owkin logo

Deep learning for deconvolution Intern - Owkin

View Company Profile
Job Title
Deep learning for deconvolution Intern
Job Location
Paris - Nantes
Job Description

About us

Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner.

Owkin has raised over $300 million and became a unicorn through investments from leading biopharma companies (Sanofi and BMS) and venture funds (Fidelity, GV and BPI, among others).

Owkin is seeking the best and brightest to join our fast-growing and dynamic team.

About the role:

The Owkin R&D department aims at making new biomedical discoveries building on high-quality datasets. Blending expert data science teams with background in computational biology and machine learning, the department provides solutions in biomarker discovery, drug positioning and optimized clinical trials.

The Applied Discovery group of Owkin R&D is looking for a promising research intern to focus on deep learning methodologies to connect bulk RNA-seq and single-cell RNA-seq to predict cell type fractions from mixtures. As part of the project, the intern will have the opportunity to survey, implement and compare existing approaches, as well as develop new methodologies. We expect the intern to collaborate closely with the multidisciplinary teams.

This internship provides a unique opportunity to study a fast-growing and important field, with clear applications for target identification.

As your main missions, you will:

  • Collaborate closely with, and receive mentorship from the other members of the R&D team;
  • Conduct primary research and numerical validation on your topic of study, including re-usable software implementations;
  • Contribute to regular research review;
  • Report your detailed findings to the group.

This position is primarily based in Paris, France. Ideally you are able to join the team in Oct, or early Nov.

 

About you

Required qualifications / experience:

  • MSc year 2+ level in machine learning;
  • Motivation to work at the intersection of biology and AI
  • Excellence in communication and technical writing
  • Experience in Linux/Unix-like environments and Python
  • Experience with deep learning frameworks (Tensorflow, PyTorch, etc.)
  • Fluent in English (spoken and written)
  • Authorization to work legally in France

Preferred qualifications/bonus:

  • Experience working with omics data (e.g RNAseq, scRNAseq)
  • Experience developing and training deep generative models (e.g VAE)
  • Participation in data science projects and competitions
  • Fluency with Git and basic software engineering patterns
  • Contribution to publications in conferences and journals 

 

Please submit your CV in English

What we offer

  • Flexible work organization and access to remote work
  • Friendly and informal working environment
  • Opportunity to work with an international team with high technical and scientific backgrounds

Recruitment Process & Security

  • Please complete the form and submit your CV.
  • Owkin is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, sex, gender, sexual orientation, age, color, religion, national origin, protected veteran status or on the basis of disability.
  • Owkin is a great place to work. Unfortunately, being a coveted workplace means we are vulnerable to recruitment phishing scams. We urge all job seekers and candidates to be wary of potential scams. Most of these have individuals posing as representatives of prominent companies, including Owkin, with the aim of obtaining personal, sensitive, or financial information from applicants. These scams prey upon an individual’s desire to obtain a job and can sometimes “feel” like a genuine recruitment process. Some red flags are identified below. Should you encounter a recruitment process that claims to be for Owkin but is not consistent with the below, please do not provide any personal or financial information:
  • Legitimate Owkin recruitment processes include communication with candidates through recognized professional networks, such as LinkedIn. 
  • Communication is always through an official Owkin email address (from the @owkin.com domain), over the phone or though our applicant tracking system (Greenhouse).
  • The Owkin talent team do use platforms such as LinkedIn and Job Teaser, however if you have any concern or doubt about this contact, please ask for them to send an email from @Owkin.com.
  • The Owkin talent team will not solicit personal data from candidates during the application phase including, but not limited to, date of birth, social security numbers, or bank account information;
  • Legitimate Owkin interviews may be conducted over the phone, in person, or via an approved enterprise videoconferencing service (Google Meets). They will not occur via Signal, Telegram or Messenger
  • Owkin offers of employment are based on merit and only extended once a candidate has interviewed with members of the talent and hiring team. Offers will be extended both verbally and in written format.

 

If you think that you have been a victim of fraud, 

Everything You Need, One Platform.

From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?

Start your free trial today!


Stay Ahead of the Curve

Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.

Owkin Headquarters Location

New York, NY

View on map

Owkin Company Size

Between 200 - 500 employees

Owkin Founded Year

2016

Owkin Total Amount Raised

$304,100,000

Owkin Funding Rounds

View funding details
  • Series B

    $50,000,000 USD

  • Series B

    $180,000,000 USD

  • Series A

    $18,000,000 USD

  • Series A

    $25,000,000 USD

  • Series A

    $13,000,000 USD

  • Series A

    $5,000,000 USD

  • Series A

    $11,000,000 USD

  • Seed

    $2,100,000 USD